Ali Asif
Chief Financial Officer
Ali Asif has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Apr 21, 2026.
On the most recent filing, Ali Asif is listed as Chief Financial Officer at Protagonist Therapeutics, Inc. Inside the rolling window, Ali Asif reported no open-market purchases and 4 open-market sales totaling $7.3M in PTGX. The largest disclosed transaction in the window is a sale of 46,203 PTGX shares on Jan 27, 2026, worth $3.8M.
Companies traded
Other insiders at PTGX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Ali Asif made?
Ali Asif has filed 5 SEC Form 4 filings (10 transaction rows) across 1 company since 2026.
Which companies does Ali Asif trade?
Ali Asif has filed SEC Form 4 disclosures for 1 company, including PTGX.
When was Ali Asif's most recent SEC Form 4 filing?
Ali Asif's most recent SEC Form 4 filing on Tracefour is dated Apr 21, 2026.
What is Ali Asif's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Ali Asif is listed as Chief Financial Officer.
What is Ali Asif's total buy and sell value in the current window?
Inside the rolling retention window, Ali Asif bought $0 and sold $7.3M based on SEC Form 4 filings.
What was Ali Asif's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 46,203 PTGX shares on 2026-01-27, worth $3.8M, per SEC Form 4 filings.